ResearchMoz

Transcatheter Heart Valve Market Outlook, 2013 - Approval of Second Generation Prosthetics and Increasing Surgeons Confidence and Proficiency to Drive TAVR Procedure Volumes

GBI Research
Published Date » 2013-06-26
No. Of Pages » N/A
   
 GBI Research’s “Transcatheter Transcatheter Heart Valve Market Outlook, 2013 - Approval of Second Generation Prosthetics and Increasing Surgeons’ Confidence and Proficiency to Drive TAVR Procedure Volumes” report examines the market, competitive landscape, and trends for the Transcatheter Heart Valves (THVs) market. The report provides comprehensive information on the key trends affecting these segments, and key analytical content related to market dynamics. The report also reviews the competitive landscape and provides a detailed analysis of the pipeline products for each segment, as well as details of important Mergers and Acquisitions (M&A) deals. The report has been compiled using data and information sourced from proprietary databases, primary and...
Table of Content

1Table of Contents
1.1List of Tables
1.2List of Figures

2Introduction
2.1Overview
2.1.1Transcatheter Heart Valve Implantation
2.1.2Routes of Access

3Disease Overview and Epidemiology
3.1Epidemiology
3.2Market Access - Distribution and Supply Chain
3.2.1Supply-side Dynamics
3.2.2Demand-side Dynamics
3.3Reimbursement Trends
3.3.1US
3.3.2Canada
3.3.3Germany
3.3.4France
3.3.5UK
3.3.6Spain
3.3.7Italy
3.3.8Japan
3.3.9India
3.3.10China

4Analyst Comments

5Global Transcatheter Heart Valve Market: Market Characterization
5.1Global Transcatheter Heart Valve Market, Revenue ($m), 2007–2012
5.2Global Transcatheter Heart Valve Market, Procedures, 2007–2012
5.3Global Transcatheter Heart Valve Market, Revenue ($m), 2012–2017
5.4Global Transcatheter Heart Valve Market, Procedures, 2012–2017
5.5Transcatheter Heart Valves, Global, Company Shares (%), 2012–2015
5.6Global Transcatheter Heart Valve Market: Key Trends
5.6.1Results from Ongoing Clinical Trials will be Important for Determining the Potential of Transcatheter Aortic Heart Valve Replacement in Lower-risk Patients
5.6.2Major Cardiovascular Companies are Seeking Small Companies with Transcatheter Heart Valve Replacement Technology to Strengthen their Portfolios
5.6.3Second-generation Prosthetics and Simplification of Procedures to Drive Long-term Growth
5.6.4High Percentage of Patients with Severe Aortic Stenosis without Treatment is Expected to Drive Future Growth of the Market
5.6.5Transcatheter Valve in Valve Procedures for Degenerative Bioprosthetic Surgical Valves will Gain Adoption in Future
5.7Global Transcatheter Heart Valve Market: Market Dynamics
5.7.1Market Drivers
5.7.2Market Restraints

6Global Transcatheter Heart Valve Market: Opportunity and Risk Analysis

7Global Transcatheter Heart Valve Market: Pipeline Analysis
7.1Profiles of Promising Products under Clinical Development
7.1.118F Direct Flow Medical Transcatheter Aortic Valve System
7.1.222 F Percutaneous Aortic Valve System
7.1.331 Millimeter CoreValve System
7.1.4Acurate TF
7.1.5Balloon Expandable Paniagua Heart Valve
7.1.6Colibri TAVR Device
7.1.7Cormove Percutaneous Aortic Valve
7.1.8Edwards Centera Valve
7.1.9Edwards Sapien 3 Valve
7.1.10Edwards Sapien Pulmonic Transcatheter Heart Valve
7.1.11Edwards Sapien XT - Ascendra 2 Delivery System
7.1.12Edwards Sapien XT Valve - NovaFlex Delivery System
7.1.13Engager Transcatheter Aortic Valve Implantation System
7.1.14Inovare Valve
7.1.15Intuity Valve System
7.1.16Intuity Valve System
7.1.17Lotus Aortic Valve System
7.1.18Lutter Valve
7.1.19Native Outflow Tract Transcatheter Pulmonary Valve
7.1.20Neovasc Tiara - Transapical Version
7.1.21Percutaneous Aortic Valve
7.1.22PercValve
7.1.23Portico Transapical Aortic Heart Valve System
7.1.24Portico Transfemoral Aortic Heart Valve System
7.1.25Self Expandable Paniagua Heart Valve
7.1.26Transfemoral TAVR System
7.1.27Percutaneous Transfemoral Transcatheter Mitral Heart Valve
7.1.28Transcatheter Aortic Valve Implantation System
7.1.29Transcatheter Mitral Valve
7.1.30Transcatheter Mitral Valve Replacement System

8Global Transcatheter Heart Valve Market: Country Analysis
8.1Global Transcatheter Heart Valve Market: Cross-Country Analysis, Forecast Revenue, By Country
8.1.1Transcatheter Heart Valve Market, US, Revenue ($m), 2012–2017
8.1.2Transcatheter Heart Valve Market, US, Procedures, 2012–2017
8.1.3Transcatheter Heart Valve Market, US, Key Company Shares (%), 2012
8.1.4Transcatheter Heart Valve Market, Germany, Revenue ($m), 2007–2012
8.1.5Transcatheter Heart Valve Market, Germany, Procedures, 2007–2012
8.1.6Transcatheter Heart Valve Market, Germany, Revenue ($m), 2012–2017
8.1.7Transcatheter Heart Valve Market, Germany, Procedures, 2012–2017
8.1.8Transcatheter Heart Valve Market, Germany, Company Shares (%), 2012
8.1.9Transcatheter Heart Valve Market, France, Revenue ($m), 2007–2012
8.1.10Transcatheter Heart Valve Market, France, Procedures, 2007–2012
8.1.11Transcatheter Heart Valve Market, France, Revenue ($m), 2012–2017
8.1.12Transcatheter Heart Valve Market, France, Procedures, 2012–2017
8.1.13Transcatheter Heart Valve Market, France, Company Shares (%), 2012
8.1.14Transcatheter Heart Valve Market, UK, Revenue ($m), 2007–2012
8.1.15Transcatheter Heart Valve Market, UK, Procedures, 2007–2012
8.1.16Transcatheter Heart Valve Market, UK, Revenue ($m), 2012–2017
8.1.17Transcatheter Heart Valve Market, UK, Procedures, 2012–2017
8.1.18Transcatheter Heart Valve Market, UK, Company Shares (%), 2012
8.1.19Transcatheter Heart Valve Market, Italy, Revenue ($m), 2007–2012
8.1.20Transcatheter Heart Valve Market, Italy, Procedures, 2007–2012
8.1.21Transcatheter Heart Valve Market, Italy, Revenue ($m), 2012–2017
8.1.22Transcatheter Heart Valve Market, Italy, Procedures, 2012–2017
8.1.23Transcatheter Heart Valve Market, Italy, Company Shares (%), 2012
8.1.24Transcatheter Heart Valve Market, Spain, Revenue ($m), 2007–2012
8.1.25Transcatheter Heart Valve Market, Spain, Procedures, 2007–2012
8.1.26Transcatheter Heart Valve Market, Spain, Revenue ($m), 2012–2017
8.1.27Transcatheter Heart Valve Market, Spain, Procedures, 2012–2017
8.1.28Transcatheter Heart Valve Market, Spain, Company Shares (%), 2012
8.1.29Transcatheter Heart Valve Market, Japan, Revenue ($m), 2012–2017
8.1.30Transcatheter Heart Valve Market, Japan, Procedures, 2012–2017

9Global Transcatheter Heart Valve Market: A Comparison of Commercially Available Transcatheter Heart Valves and Company Profiles
9.1Global Transcatheter Heart Valve Market: Key Company Profiles
9.1.1Edwards Lifesciences
9.1.2Medtronic
9.1.3JenaValve
9.1.4Symetis
9.1.5AorTech International plc
9.1.6Boston Scientific
9.1.7Bracco SpA
9.1.8Braile Biomedica
9.1.9Direct Flow Medical
9.1.10St. Jude Medical
9.1.11Transcatheter Technologies GmbH
9.1.12ValveXchange

10Global Transcatheter Heart Valve Market: Consolidation Landscape
10.1Key Deals 2008–2012
10.1.1Edwards Lifesciences’ Acquisition of Embrella Cardiovascular, 2011
10.1.2Boston Scientific’s Acquisition of Sadra Medical, 2011
10.1.3Bracco AMT’s Acquisition of Heart Leaflet Technologies, 2010
10.1.4Medtronic’s Acquisition of CoreValve, 2009
10.1.5Medtronic’s Acquisition of Ventor, 2009
10.1.6Abbott Laboratories’ Acquisition of Evalve, 2009

11Appendix
11.1Definitions
11.1.1Transcatheter Heart Valves
11.2Acronyms
11.3Sources
11.4Research Methodology
11.4.1Secondary Research
11.4.2Primary Research
11.4.3Models
11.4.4Forecasts
11.4.5Expert Panels
11.5Contact Us
11.6Disclaimer

List of Tables


Table 1:Transcatheter Heart Valve Market, Global, Revenue ($m), 2007–2012
Table 2:Transcatheter Heart Valve Market, Global, Procedures, 2007–2012
Table 3:Transcatheter Heart Valve Market, Global, Revenue Forecast ($m), 2012–2017
Table 4:Transcatheter Heart Valve Market, Global, Procedures Forecast, 2012–2017
Table 5:Transcatheter Heart Valve Market, Global, Company Shares (%), 2012–2015
Table 6:Transcatheter Heart Valve Market, Global, Transcatheter Aortic Valve Replacement for Degenerative Bioprosthetic Surgical Valves: Results from The Global Valve-In-Valve Registry, 2013
Table 7:Transcatheter Heart Valve Market, Global, Revenue Forecast by Type of Heart Valve ($m),
2012–2017
Table 8:Transcatheter Heart Valve Market, Global, Pipeline Products I, 2013
Table 9:Transcatheter Heart Valve Market, Global, Pipeline Products II, 2013
Table 10:18F Direct Flow Medical Transcatheter Aortic Valve System, Product Status, 2013
Table 11:22 F Percutaneous Aortic Valve System, Product Status, 2013
Table 12:31 Millimeter CoreValve System, Product Status, 2013
Table 13:Acurate TF, Product Status, 2013
Table 14:Balloon Expandable Paniagua Heart Valve, Product Status, 2013
Table 15:Colibri TAVR Device, Product Status, 2013
Table 16:Cormove Percutaneous Aortic Valve, Product Status, 2013
Table 17:Edwards Centera Valve, Product Status, 2013
Table 18:Edwards Sapien 3 Valve, Product Status, 2013
Table 19:Edwards Sapien Pulmonic Transcatheter Heart Valve, Product Status, 2013
Table 20:Edwards Sapien XT - Ascendra 2 Delivery System, Product Status, 2013
Table 21:Edwards Sapien XT Valve - NovaFlex Delivery System, Product Status, 2013
Table 22:Engager Transcatheter Aortic Valve Implantation System, Product Status, 2013
Table 23: Inovare Valve, Product Status, 2013
Table 24:Intuity Valve System, Product Status, 2013
Table 25:Intuity Valve System, Product Status, 2013
Table 26:Lotus Aortic Valve System, Product Status, 2013
Table 27: Lutter Valve, Product Status, 2013
Table 28: Native Outflow Tract Transcatheter Pulmonary Valve, Product Status, 2013
Table 29:Neovasc Tiara - Transapical Version, Product Status, 2013
Table 30:Percutaneous Aortic Valve, Product Status, 2013
Table 31:PercValve, Product Status, 2013
Table 32:Portico Transapical Aortic Heart Valve System, Product Status, 2013
Table 33:Portico Transfemoral Aortic Heart Valve System, Product Status, 2013
Table 34:Self Expandable Paniagua Heart Valve, Product Status, 2013
Table 35:Transfemoral TAVR System, Product Status, 2013
Table 36:Percutaneous Transfemoral Transcatheter Mitral Heart Valve, Product Status, 2013
Table 37:Transcatheter Aortic Valve Implantation System, Product Status, 2013
Table 38:Transcatheter Mitral Valve, Product Status, 2013
Table 39:Transcatheter Mitral Valve Replacement System, Product Status, 2013
Table 40:Transcatheter Heart Valve Market, Global, Cross-country Analysis, Compound Annual Growth Rate (%), 2007–2017
Table 41:Transcatheter Heart Valve Market, US, Revenue Forecast ($m), 2012–2017
Table 42:Transcatheter Heart Valve Market, US, Procedures Forecast, 2012–2017
Table 43:Transcatheter Heart Valve Market, Germany, Revenue ($m), 2007–2012
Table 44:Transcatheter Heart Valve Market, Germany, Procedures, 2007–2012
Table 45:Transcatheter Heart Valve Market, Germany, Revenue Forecast ($m), 2012–2017
Table 46:Transcatheter Heart Valve Market, Germany, Procedures Forecast, 2012–2017
Table 47:Transcatheter Heart Valve Market, Germany, Company Shares (%), 2012
Table 48:Transcatheter Heart Valve Market, France, Revenue ($m), 2007–2012
Table 49:Transcatheter Heart Valve Market, France, Procedures, 2007–2012
Table 50:Transcatheter Heart Valve Market, France, Revenue Forecast ($m), 2012–2017
Table 51:Transcatheter Heart Valve Market, France, Procedures Forecast, 2012–2017
Table 52:Transcatheter Heart Valve Market, France, Company Shares (%), 2012
Table 53:Transcatheter Heart Valve Market, UK, Revenue ($m), 2007–2012
Table 54:Transcatheter Heart Valve Market, UK, Procedures, 2007–2012
Table 55:Transcatheter Heart Valve Market, UK, Revenue Forecast ($m), 2012–2017
Table 56:Transcatheter Heart Valve Market, UK, Procedures Forecast, 2012–2017
Table 57:Transcatheter Heart Valve Market, UK, Company Shares (%), 2012
Table 58:Transcatheter Heart Valve Market, Italy, Revenue ($m), 2007–2012
Table 59:Transcatheter Heart Valve Market, Italy, Procedures, 2007–2012
Table 60:Transcatheter Heart Valve Market, Italy, Revenue Forecast ($m), 2012–2017
Table 61:Transcatheter Heart Valve Market, Italy, Procedures Forecast, 2012–2017
Table 62:Transcatheter Heart Valve Market, Italy, Company Shares (%), 2012
Table 63:Transcatheter Heart Valve Market, Spain, Revenue ($m), 2007–2012
Table 64:Transcatheter Heart Valve Market, Spain, Procedures, 2007–2012
Table 65:Transcatheter Heart Valve Market, Spain, Revenue Forecast ($m), 2012–2017
Table 66:Transcatheter Heart Valve Market, Spain, Procedures Forecast, 2012–2017
Table 67:Transcatheter Heart Valve Market, Spain, Company Shares (%), 2012
Table 68:Transcatheter Heart Valve Market, Japan, Revenue Forecast ($m), 2012–2017
Table 69:Transcatheter Heart Valve Market, Japan, Procedures Forecast, 2012–2017
Table 70:Sapien, PARTNER EU Trial, 2007
Table 71:Sapien, The PARTNER US TRIAL, 2007
Table 72:Sapien, The SOURCE Registry Trial (Cohort 1), 2009
Table 73:CoreValve Registry Trial, 2008
Table 74:JenaValve, CE Mark Study, 2010
Table 75:Acurate TA, First In Man Trial, 2011

List of Figures


Figure 1:Transcatheter Heart Valve Market, US, Prevalence of Moderate-to-severe Valve Disease (%), 2011
Figure 2:Transcatheter Heart Valve Market, Global, Reimbursement Trends, 2013
Figure 3:Transcatheter Heart Valve Market, Global, Revenue ($m), 2007–2012
Figure 4:Transcatheter Heart Valve Market, Global, Procedures, 2007–2012
Figure 5:Transcatheter Heart Valve Market, Global, Revenue Forecast ($m), 2012–2017
Figure 6:Transcatheter Heart Valve Market, Global, Procedures Forecast, 2012–2017
Figure 7:Transcatheter Heart Valve Market, Global, Company Shares (%), 2012–2015
Figure 8:Transcatheter Heart Valve Market, Global, Key Trends, 2013
Figure 9:Transcatheter Heart Valve Market, Global, Consolidation Snap Shot, 2013
Figure 10:Transcatheter Heart Valve Market, Global, Advances in Technology and Procedures, 2013
Figure 11:Transcatheter Heart Valve Market, Global, Untreated Severe Aortic Stenosis Patients, 2013
Figure 12:Transcatheter Heart Valve Market, Global, Market Dynamics, 2013
Figure 13:Transcatheter Heart Valve Market, Global, Proportion of Population Aged 60 and Above (%), 2011–2020
Figure 14:Transcatheter Heart Valve Market, Global, TAVR vs. SAVR, PARTNER Cohort A Results, 2013
Figure 15:Transcatheter Heart Valve Market, Global, Opportunity and Risk Analysis, 2013
Figure 16:Transcatheter Heart Valve Market, Global, Revenue Forecast by Type of Heart Valve ($m),
2012–2017
Figure 17:Transcatheter Heart Valve Market, Global, Key Pipeline Products, 2013
Figure 18:Transcatheter Heart Valve Market, Global, Cross-country Analysis, Compound Annual Growth Rate (%), 2007–2017
Figure 19:Transcatheter Heart Valve Market, US, Revenue Forecast ($m), 2012–2017
Figure 20:Transcatheter Heart Valve Market, US, Procedures Forecast, 2012–2017
Figure 21:Transcatheter Heart Valve Market, Germany, Revenue ($m), 2007–2012
Figure 22:Transcatheter Heart Valve Market, Germany, Procedures, 2007–2012
Figure 23:Transcatheter Heart Valve Market, Germany, Revenue Forecast ($m), 2012–2017
Figure 24:Transcatheter Heart Valve Market, Germany, Procedures Forecast, 2012–2017
Figure 25:Transcatheter Heart Valve Market, Germany, Company Shares (%), 2012
Figure 26:Transcatheter Heart Valve Market, France, Revenue ($m), 2007–2012
Figure 27:Transcatheter Heart Valve Market, France, Procedures, 2007–2012
Figure 28:Transcatheter Heart Valve Market, France, Revenue Forecast ($m), 2012–2017
Figure 29:Transcatheter Heart Valve Market, France, Procedures Forecast, 2012–2017
Figure 30:Transcatheter Heart Valve Market, France, Company Shares (%), 2012
Figure 31:Transcatheter Heart Valve Market, UK, Revenue ($m), 2007–2012
Figure 32:Transcatheter Heart Valve Market, UK, Procedures, 2007–2012
Figure 33:Transcatheter Heart Valve Market, UK, Revenue Forecast ($m), 2012–2017
Figure 34:Transcatheter Heart Valve Market, UK, Procedures Forecast, 2012–2017
Figure 35:Transcatheter Heart Valve Market, UK, Company Shares (%), 2012
Figure 36:Transcatheter Heart Valve Market, Italy, Revenue ($m), 2007–2012
Figure 37:Transcatheter Heart Valve Market, Italy, Procedures, 2007–2012
Figure 38:Transcatheter Heart Valve Market, Italy, Revenue Forecast ($m), 2012–2017
Figure 39:Transcatheter Heart Valve Market, Italy, Procedures Forecast, 2012–2017
Figure 40:Transcatheter Heart Valve Market, Italy, Company Shares (%), 2012
Figure 41:Transcatheter Heart Valve Market, Spain, Revenue ($m), 2007–2012
Figure 42:Transcatheter Heart Valve Market, Spain, Procedures, 2007–2012
Figure 43:Transcatheter Heart Valve Market, Spain, Revenue Forecast ($m), 2012–2017
Figure 44:Transcatheter Heart Valve Market, Spain, Procedures Forecast, 2012–2017
Figure 45:Transcatheter Heart Valve Market, Spain, Company Shares (%), 2012
Figure 46:Transcatheter Heart Valve Market, Japan, Revenue Forecast ($m), 2012–2017
Figure 47:Transcatheter Heart Valve Market, Japan, Procedures Forecast, 2012–2017
Figure 48:Comparison of Commercially Available Transcatheter Heart Valves, 2013
Figure 49:Global Transcatheter Heart Valves Market, Product Benchmarking, 2013
Figure 50:Edwards Lifesciences, PARTNER Trial, Study Design, 2007

Upcoming Reports:

Bio-Based Polyurethane Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
Polyurethanes are used in a wide range of industrial applications due to their chemical versatility, high performance and low cost. They find use in building and construction, consumer products, furniture and fixtures, transportation and in industrial applications. Polyurethane is traditionally a downstream derivative of crude oil, rendering it susceptible to the crude oil market fluctuations. Moreover in this age of the consumers, and the global inclination towards green products and sustainable development, bio based alternative for crude oil is the need of the day. Polyurethane...
Ambulatory Blood Pressure Monitoring Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
By - Transparency Market Research
Ambulatory blood pressure monitoring includes measurement of blood pressure at regular intervals of time usually after every 15-20 minutes and is performed for 24 hours, during which patient conducts normal day to day activities. Ambulatory blood pressure monitors are portable automated monitor worn on a belt connected to standard cuff on upper arm. The device uses an oscillometric technique to identify systolic, diastolic, mean blood pressure and heart rate. Ambulatory blood pressure monitoring provides valuable and precise diagnostic information in comparison to in-clinic and home...
Theranostics Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts 2012 - 2018
By - Transparency Market Research
Theranostics is the fusion of drug therapy and diagnostics to optimize effectiveness, safety, and streamline drug development. Combination of medical drugs with diagnostic tests is also known as integrated medicine, pharmacodiagnostics, companion diagnostics, and Dx/Rx partnering. Theranostics market is an emerging field which is generating strong interest from healthcare industry and regulatory bodies. It is an emerging clinical diagnostics field that focuses on developing specific analysis to predict the use of most significant drug for patient. This technique uses molecular...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Nuclear Development Plans in China Gets Fresh Impetus
Mar 5, 2015  
The nuclear development plans of China got a renewed momentum on Wednesday as State Council gave a nod to build new reactors at the nuclear power plant located near Hongyan River. The unit 5 and 6 of the nuclear plant near Hongyan River, located in the northeastern province of Liaoning got approval for construction from the State Council. The council also mentioned that the construction should...
Indian Telecoms Bid at Spectrum War
Mar 5, 2015  
The Indian government on Wednesday managed to mop up nearly INR 60,000 crore with the spectrum auctions off to a wonderful start. Top bidders included Idea Cellular, Bharti Airtel, and Vodafone India who fought tooth and nail to gain secure airwaves in those areas where their licenses were nearing expiration. Reliance Jio Infocomm made a strenuous attempt to acquire as many data airwaves as...
South Korean Pharmaceutical Companies Extend Business with Saudi Arabia
Mar 5, 2015  
Four South Korean pharmaceutical companies will export their products to Saudi Arabia, including anticancer drugs and antibiotics, for the coming five years, South Korea’s Health Ministry informed this Wednesday, as a result of South Korean President Park Geun-hye's business trip to the Saudi Arabia this week. Ascertaining to the export agreement, representatives of these four Korean...
U.K. Government Slow to Stop Pharma R&D Slump
Mar 4, 2015  
When it comes to turnaround strategies, the focal point of the U.K. government is currently the life sciences industry. Recent data however shows that healthcare companies are spending less and less on research and development processes on drugs in the country. The Office of National Statistics released the data earlier this week. It shows the United Kingdom’s drug production...
Sun Pharma Buys Out GSK Australian Opiates Business
Mar 4, 2015  
Global pharmaceutical giant GSK announced on Tuesday that they had come to an agreement with Sun Pharmaceuticals Industries for the latter to buy out the opiates business in Australia owned by GSK. A joint statement was made by the two pharma top companies. The statement said that the companies’ respective wholly owned subsidiaries had already come to an agreement that was...